Pyxis Oncology, Inc. · NASDAQ:PYXS
BlackRock, Inc. reported a 5.60% stake in Pyxis Oncology, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 4, 2025
BlackRock, Inc. reported a 5.60% stake in Pyxis Oncology, Inc., 3,344,141 shares, as a passive investor on Dec 31, 2024. Filed Feb 4, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 3,344,141
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.60% | 3,344,141 |
Source
Related
- Pyxis Oncology, Inc.
- BlackRock, Inc.
- Pyxis Oncology, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G/A · GordonMD Global Investments LP · Oct 9, 2026
- Schedule 13G · Coastlands Capital LP · Oct 5, 2026
- Form 4 · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G/A · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Jul 10, 2026